ICYMI: New approvals by the FDA in 2021 offer greater treatment options for patients
The U.S. Food and Drug Administration (FDA) approved a total of 60 new drugs in 2021. Anew report from the FDA catalogs 50 new approvals by the Center for Drug Evaluation and Research (CDER). Separately, the Center for Biologics Evaluation and Research (CBER)approved 10. These novel medicines offer to transform many debilitating diseases, resulting in improved survival, better health outcomes, enhanced quality of life — and in many cases, they provide a first-time treatment option for patients.
Source: The Catalyst - Category: Pharmaceuticals Authors: Richard Moscicki, M.D. Tags: Research and Development FDA PDUFA New Era of Medicine & D Focus Source Type: news
More News: Food and Drug Administration (FDA) | Pharmaceuticals